Conditional gene vectors regulated in cis

Nucleic Acids Research

Volumn 36, Issue 13, 2008, Pages

  Pich, Dagmar ^a   Humme, Sibille ^a   Spindler, Mark Peter ^a   Schepers, Aloys ^a   Hammerschmidt, Wolfgang ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; DOXYCYCLINE; PLASMID DNA; PLASMID VECTOR; EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN; HIGH MOBILITY GROUP A1A PROTEIN; HYBRID PROTEIN; REPRESSOR PROTEIN; TETRACYCLINE RESISTANCE ENCODING TRANSPOSON REPRESSOR PROTEIN; TETRACYCLINE RESISTANCE-ENCODING TRANSPOSON REPRESSOR PROTEIN;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DNA REPLICATION; EMBRYO; EPSTEIN BARR VIRUS; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RAT; TARGET CELL; ANIMAL; BIOSYNTHESIS; CELL LINE; CHEMISTRY; GENE VECTOR; GENETICS; METABOLISM; PLASMID;

HUMAN HERPESVIRUS 4;

ALLOSTERIC REGULATION; ANIMALS; CELL LINE; DNA REPLICATION; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENETIC VECTORS; HMGA1A PROTEIN; HUMANS; PLASMIDS; RATS; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS;

EID: 48349131672     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn273     Document Type: Article

References (49)

1. Kay,M.A., Glorioso,J.C. and Naldini,L. (2001) Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics. Nat. Med., 7, 33-40.
2. Cornu,T.I. and Cathomen,T. (2007) Targeted genome modifications using integrase-deficient lentiviral vectors, Mol. Ther., 15, 2107-2113.
3. Lombardo,A., Genovese,P., Beausejour,C.M., Colleoni,S., Lee,Y.L., Kim,K.A., Ando,D., Urnov,F.D., Galli,C., Gregory,P.D. et al. (2007) Gene editing in human stem cells using zinc finger nuclcases and integrase-defective lentiviral vector delivery. Nat. Biotechnol., 25, 1298-1306.
4. Moehle,E.A., Rock,J.M., Lee,Y.L., Jouvenot,Y., DeKelver,R.C., Gregory,P.D., Urnov,F.D. and Holmes,M.C. (2007) Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc. Natl Acad. Sci. USA, 104, 3055-3060.
5. Urnov,F.D., Miller,J.C., Lee,Y.L., Beausejour,C.M., Rock,J.M., Augustus,S., Jamieson,A.C., Porteus,M.H., Gregory,P.D. and Holmes,M.C. (2005) Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature, 435, 646-651.
6. Hacein-Bey-Abina,S., Von Kalle,C., Schmidt,M., McCormack,M.P., Wulffraat,N., Leboulch,P., Lim,A., Osborne,C.S., Pawliuk,R., Morillon,E. et al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-XI. Science, 302, 415-419.
7. Sugden,B. and Leight,E.R. (2001) EBV's plasmid replicon: An enigma in cis and trans. Curr. Top. Microbiol. Immunol., 258, 3-11.
8. Jackson,D.A., Juranek,S. and Lipps,H.J. (2006) Designing nonviral vectors for efficient gene transfer and long-term gene expression. Mol. Ther., 14, 613-626.
9. Baiker,A., Maercker,C., Piechaczek,C., Schmidt,S.B., Bode,J., Benham,C. and Lipps,H.J. (2000) Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix. Nat. Cell Biol., 2, 182-184.
10. Schaarschmidt,D., Baltin,J., Stehle,I.M., Lipps,H.J. and Knippers,R. (2004) An episomal mammalian replicon: Sequence-independent binding of the origin recognition complex EMBO 23, 191-201.
11. Wang,J. and Sugden,B, (2005) Origins of bidirectional replication of Epstein-Barr virus: Models for understanding mammalian origins of DNA synthesis. J. Cell. Biochem., 94, 247-256.
12. Kapoor,P. and Frappier,L. (20P3) EBNA1 partitions Epstein-Barr virus plasmids in yeast cells by attaching to human EBNA1-binding protein 2 on mitotic chromosomes. J. Virol., 77, 6946-6956.
13. Marechal,V., Dehee,A., Chikhi-Brachet,R., Piolot,T., Coppey-Moisan,M. and Nicolas,J.C. (1999) Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J. Virol., 73, 4385-4392.
14. Hung,S.C., Kang,M.S. and Kieff,E. (2001) Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. Proc. Natl Acad. Sci. USA, 98, 1865-1870.
15. Sears,J., Ujihara,M., Wong,S., Ott,C., Middeldorp,J. and Aiyar,A. (2004) The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J. Virol., 78, 11487-11505.
16. Reeves,R. (2001) Molecular biology of HMGA proteins: Hubs of nuclear function. Gene, 277, 63-81.
17. Harrer,M., Luhrs,H., Bustin,M., Scheer,U. and Hock,R. (2004) Dynamic interaction of HMGA1a proteins with chromatin. J. Cell Sci., 117, 3459-3471.
18. Thomae,A.W., Pich,D., Brocher,J., Spindler,M.P., Berens,C., Hock,R., Hammerschmidt,W. and Schepers,A. (2008) Interaction between HMGA1a and the origin recognition complex creates site-specific replication origins. Proc. Natl Acad. Sci. USA, 105, 1692-1697.
19. Schepers,A., Ritzi,M., Bousset,K., Kremmer,E., Yates,J.L., Harwood,J., Diffley,J.F. and Hammerschmidt,W. (2001) Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. EMBO J., 20, 4588-4602.
20. Graham,F.L., Smiley,J., Russell,W.C. and Nairn,R. (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol., 36, 59-74.
21. Takada,K., Horinouchi,K., Ono,Y., Aya,T., Osato,T., Takahashi,M. and Hayasaka,S. (1991) An Epstein-Barr virus-producer line Akata: establishment of the cell fine and analysis of viral DNA. Virus Genes 5, 147-156.
22. Wang,D., Liebowitz,D. and Kieff,E. (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell, 43, 831-840.
23. Graham,F.L., Bacchetti,S., McKinnon,R., Cordell,B. and Goodman,H. (1979) Transformation of mammalian cells with DNA using the calcium technique. Wistar Inst. Symp. Monogr., 1, 3-25.
24. Krueger,C., Berens,C., Schmidt,A., Schnappinger,D. and Hillen,W. (2003) Single-chain Tet transregulators. Nucleic Acids Res., 31, 3050-3056.
25. Hirt,B. (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol., 26, 365-369.
26. Ritzi,M., Tillack,K., Gerhardt,J., Ott,E., Humme,S., Kremmer,E., Hammerschmidt,W. and Schepers,A. (2003) Complex protein-DNA dynamics at the latent origin of DNA replication of Epstein-Barr virus. J. Cell. Sci., 116, 3971-3984.
27. Meuth,M. and Green,H. (1974) Induction of a deoxycytidineless state in cultured mammalian cells by bromodeoxyuridine. Cell, 2, 109-112.
28. Postle,K., Nguyen,T.T. and Bertrand,K.P. (1984) Nucleotide sequence of the repressor gene of the TN10 tetracycline resistance determinant. Nucleic Acids Res., 12, 4849-4863.
29. Kleinschmidt,C., Tovar,K., Hillen,W. and Porschke,D. (1988) Dynamics of repressor-operator recognition: The Tn10-encoded tetracycline resistance control. Biochemistry, 27, 1094-1104.
30. Campbell,R.E., Tour,O., Pahner,A.E., Steinbach,P.A., Baird,G.S., Zacharias,D.A. and Tsien,R.Y. (2002) A monomeric red fluorescent protein. Proc. Natl Acad. Sci. USA, 99, 7877-7882.
31. Middleton,T. and Sugden,B. (1992) EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication. J. Virol., 66, 489-495.
32. Li,X., Zhao,X., Fang,Y., liang,X., Duong,T., Fan,C., Huang,C.C. and Kain,S.R. (1998) Generation of destabilized green fluorescent protein as a transcription reporter. J. Biol. Chem., 273, 34970-34975.
33. Kirchmaier,A.L. and Sugden,B. (1995) Plasmid maintenance of derivatives of oriP of Epstein-Barr virus. J. Virol., 69, 1280-1283.
34. Lindner,S.E., Zeller,K., Schepers,A. and Sugden,B. (2008) EBNA1's Affinity for it's origin of DNA synthesis is a determinant of the origin's replicative efficiency. J. Virol., epub ahead of print.
35. Gerhardt,J., Jafar,S., Spindler,M.P., Ott,E. and Schepers,A. (2006) Identification of new human origins of DNA replication by an origin-trapping assay. Mol. Cell. Biol., 26, 7731-7746.
36. Aiyar,A., Tyree,C. and Sugden,B. (1998) The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J., 17, 6394-6403.
37. Dhar,S.K., Yoshida,K., Machida,Y., Khaira,P., Chaudhuri,B., Wohlschlegel,J.A., Leffak,M., Yates,J. and Dutta,A. (2001) Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin. Cell, 106, 287-296.
38. Chaudhuri,B., Xu,H., Todorov,I., Dutta,A. and Yates,J.L. (2001) Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc. Natl Acad. Sci. USA, 98, 10085-10089.
39. Schonig,K., Schwenk,F, Rajewsky,K. and Bujard,H. (2002) Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res., 30, e134.
40. Urlinger,S., Baron,U., Thellmann,M., Hasan,M.T., Bujard,H. and Hillen,W. (2000) Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity. Proc. Natl Acad. Sci. USA, 97, 7963-7968.
41. Gossen,M., Freundlieb,S., Bender,G., Mueller,G., Hillen,W. and Bujard,H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science, 268, 1766-1769.
42. Delecluse,H.J., Pich,D., Hilsendegen,T., Baum,C. and Hammerschmidt,W. (1999) A first-generation packaging cell line for Epstein-Barr virus-derived vectors. Proc. Natl Acad Sci. USA, 96, 5188-5193.
43. Kreppel,F. and Kochanek,S. (2004) Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors. J. Virol., 78, 9-22.
44. Hettich,E., Janz,A., Zeidler,R., Pich,D., Hellebrand,E., Weissflog,B., Moosmann,A. and Hammerschmidt,W. (2006) Genetic design of an optimized packaging cell line for gene vectors transducing human B cells. Gene Ther., 13, 844-856.
45. White,A.E., Wade-Martins,R. and James,M.R. (2002) Infectious delivery of 120-kilobase genomic DNA by an Epstein-Barr virus amplicon vector. Mol. Ther, 5, 427-435.
46. Gomez-Sebastian,S., Gimenez-Cassina,A., Diaz-Nido,J., Lim,F. and Wade-Martins,R. (2007) Infectious delivery and expassion of a 135 kb human FRDA genomic DNA locus complements Friedreich's ataxia deficiency in human cells. Mol. Ther., 15, 248-254.
47. Manzini,S., Vargiolu,A., Stehle,I.M., Bacci,M.L., Cerrito,M.G., Giovannoni,R., Zannoni,A., Bianco,M.R., Forni,M., Donini,P. et al. (2006) Genetically modified pigs produced with a nonviral episomal vector. Proc. Natl Acad. Sci. USA, 103, 17672-17677.
48. Yates,J.L. and Camiolo,S.M. (1988) Dissection of DNA replication and enhancer activation functions of Epstein-Barr virus nuclear antigen 1. Cancer Cells, 6, 197-205.
49. Yates,J.L., Warren,N. and Sugden,B. (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature, 313, 812-815.